COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Dr. Kumud Singh

Kumud K. Singh, PhD

Kumud K. Singh, PhD

Associate Professor and Principal Investigator 

Chair, School of Medicine Student Affairs Committee (SAC)

Member, Health Sciences Committee on Educational Policy (CEP)

Associate Faculty, Training Programs in Pediatrics Infectious Diseases

Founding Member, Organizing Committee, Children Health and Education Research Seminars (CHERS) 
Faculty Instructor/Facilitator: Problem Based Learning, Clinical Foundation I/II, School of Medicine, UCSD

Faculty Supervisor in Faculty Mentor Program, UCSD

Faculty Mentor, Regents Scholar Research Initiative (RSRI), UCSD 

About the Lab

 Areas of Research Interest
Host genetic factors in susceptibility and pathogenesis of infectious diseases (HIV, respiratory viruses) and immune disorders (multiple sclerosis)
Genetic and Immune disorger diagnostic markers and therapeutic strategies for personalized medicine.
Innate Immunity and complement activation in infectious diseases and CNS impairment
Nucleic acid based rapid detection and quantitation assays for infectious agents, genotyping, gene quantitation, immune recovery (blood, cerebrospinal fluid, blood spots, cell pellets)
Sensitive ELISAs, magnetic bead based cytokine and immune response assays for plasma and csf
Pharmacogenomics of drug responses
Telomerase, telomeres, aging, Alzheimer’s disease, cancer
​Catalytic nucleic acids

News & Research

December, 2015: Poster presentation: 2015 American Society of Cell Biology (ASCB) Annual Meeting, San Diego, CA.

MBL-HIV1 gp120 immunoreactivity is associated with MAP2 somatodendritic damage, synaptic loss & complement activation in neuronal cells, gp120 transgenic mouse model and HIV infected brain.

Feb 23-26, 2015:  XXIIConference for Retroviruses and Opportunistic Infections (CROI), Seattle, WA:Singh lab presented following three posters at CROI:

1. KIR/HLA Alleles Alter CD4+ Lymphocyte Count and Viral Load in HIV Infected Children. Singh KK, Qin M, Brummel S, Farhad M, Angelidou K, Trout RN, FentonT, Spector SA.

2. MBL-HIV1gp120 Immunoreactivity is Associated with Markers of Neuronal Injury. Teodorof C, Nguyen D, Kadakia N, Maung R, Soontornniyomkij B, AchimC, Moore D, Masliah E, Kaul M, and Singh KK.

3. Synergistic Effects of MBL2/APP Polymorphisms on Neurocognitive Impairment in CHARTER. Singh KK, Deng Q, Fennema-Notestine C, Vaida F, Ellis RJ, Letendre SL, Franklin D, Rosario D, Heaton RD, Grant I, and CHARTER Group.